long-acting beta agonist


Also found in: Dictionary, Thesaurus, Encyclopedia.

long-acting beta agonist

Abbreviation: LABA
A class of medications used to treat asthma. Examples include: formoterol and salmeterol.
See also: agonist
Mentioned in ?
References in periodicals archive ?
Lemanske et al (10) performed a randomized, controlled trial in 175 adolescent and adult asthmatics to determine whether the addition of a long-acting beta agonist might allow either elimination or dose reduction of inhaled corticosteroids.
Non-Hispanic whites from both the primary and replication groups with this rare variant were more than twice as likely to experience uncontrolled, persistent symptoms during treatment with a long-acting beta agonist.
Conducted by the NHLBI's Asthma Clinical Research Network, the study compared three treatment methods: doubling the dose of inhaled corticosteroids alone, supplementing a low dose of inhaled corticosteroids with a long-acting beta agonist (salmeterol), and supplementing a low dose of inhaled corticosteroids with a long-acting anticholinergic drug (tiotropium bromide).
Before testing, the patient should refrain from use of short-acting beta agonists for 6 hours and leukotriene inhibitors, long-acting beta agonists, and cromolyn for 24 hours.
The Food and Drug Administration is requiring major changes to the prescribing information for inhaled long-acting beta agonists as part of a risk management plan to address the ongoing safety issues associated with the products' use in children and adults with asthma, the agency said at a press briefing.
Patients involved in the studies were allowed to continue on their usual care with the exception of long-acting beta agonists.
A significant number of patients suffering from eosinophilic asthma do not respond well to current treatment with inhaled corticosteroids in combination with long-acting beta agonists.
Food and Drug Administration today announced that drugs in the class of long-acting beta agonists (LABAs) should never be used alone in the treatment of asthma in children or adults.
Aerovance expects to enroll approximately 500 patients with moderate to severe asthma, in the United States and Europe, who are poorly controlled by the combination of inhaled corticosteroids (ICS) and long-acting beta agonists (LABA).